Center for Clinical Research
Study 907 & 908 - The purpose of these studies is to determine if the investigational drug can help patients with non-small cell lung cancer (Stage III/IV) increase physical function and maintain or gain muscle. Participation would last approximately 5 months.
Study 910 - The purpose of this study is to determine whether urine desmosine levels provide a reliable biomarker for disease detection and assessment of disease progression in cancer. Urine samples will be collected from participants diagnosed with lung, breast, colon cancer prior to surgical treatment who have not received chemotherapy or radiation.
Study 932- This study is for women with stage I-III breast cancer that will receive myelotoxic chemotherapy.
Breast Cancer Studies
Study 905- This study is for women at an increased risk for breast cancer or those who had breast cancer and completed their treatment.
Study 912- The purpose of this study is to assess proteins secreted during the time of lactation which are up-regulated during breast involution (post lactation). This is enrolling females 18 years of age or older, who have delivered after a full-term pregnancy and who is postpartum and has or will begin breastfeeding.
Study 919- This study if for healthy women premenopausal or postmenopausal.
Study 921- The main purpose of this study is to determine if resveratrol, a natural compound found in red grape skin, red wine, peanuts, mulberries, and certain other plants such as Japanese knotweed can effect inflammatory biomarkers and acts, at least in part, by altering gene methylation.
For more information, please contact:
Benji Hawkins, CCRC
Senior Clinical Research Coordinator